# Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA)

> **NCT00786734** · PHASE4 · WITHDRAWN · sponsor: **JW Pharmaceutical**

## Conditions studied

- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Pitavastatin
- **DRUG:** Pitavastatin

## Key facts

- **NCT ID:** NCT00786734
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-08
- **Primary completion:** 2009-05
- **Final completion:** 2010-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00786734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00786734, "Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00786734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*